Clinical Trials Logo
  1. Home
  2. Acute Urticaria
  3. NCT02024152

Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg

Acute Urticaria Clinical Trial

Clinical Trial Summary

This study is to investigate the pharmacokinetics (PK) together with the safety and tolerability of JDP-205 at 5 mg and 10 mg intravenous doses and 10 mg intramuscular dose, in comparison to the marketed cetirizine oral product Zyrtec® 10 mg tablets (an OTC product) in healthy male and female volunteers after a single dose administration.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02024152
Study type Interventional
Source JDP Therapeutics, Inc.
Contact
Status Completed
Phase Phase 1
Start date March 2011
Completion date July 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT02935699 - Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria Phase 3
Completed NCT02023164 - Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria Phase 3
Completed NCT02565680 - Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency Phase 2/Phase 3
Completed NCT02045524 - A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers Phase 1